| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;59:502-507
© 1995 The Society of Thoracic Surgeons
Divisions of Cardiac and Thoracic Surgery, Cardiology, and Cardiac Anaesthesia, University of Alberta, Edmonton, Alberta, Canada
Accepted for publication October 27, 1994.
* Address reprint requests to Dr Karmy-Jones, Department of Surgery, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202-2689.
One hundred patients undergoing elective cardiac operations were randomized into placebo (n = 54) and magnesium (n = 46) groups. The magnesium group received six doses of 2.4 g (19.2 mEq) magnesium sulfate intravenously in the first 24 hours after the cardiac operation. The magnesium group had higher serum magnesium concentrations postoperatively (1.09 ± 0.20 versus 0.75 ± 0.13 mmol/L; p < 0.0001), postoperative day 1 (1.49 ± 0.34 versus 0.70 ± 0.12 mmol/L; p < 0.0001) and postoperative day 2 (0.96 ± 0.19 versus 0.76 ± 0.07 mmol/L; p < 0.0001). Patients in the magnesium group had a lower incidence of ventricular tachyarrythmias (VTs) (17.3% versus 51.9%; p = 0.0006), less need for treatment (6.5% versus 20.3%; p < 0.0001), fewer VT episodes/patient (0.3 ± 0.8 versus 1.39 ± 1.9; p < 0.0001), and a reduction in the severity of VTs as measured by the modified Lown grade (p = 0.0002). No differences were demonstrated with respect to supraventricular tachyarrythmias. The magnesium group had reduced absolute creatine kinase-MB levels (5.3 ± 4.2 versus 28.4 ± 28 IU/L; p = 0.001) as well as creatine kinase-MB fraction (0.01 ± 0.02 versus 0.05 ± 0.04; p = 0.001) on postoperative day 1. Serum magnesium concentrations were lower during VTs than during periods of sinus rhythm (0.75 ± 0.75 versus 1.02 ± 0.35 mmol/L; p < 0.001). Patients with VTs had higher serum creatine kinase-MB levels than those that did not both postoperatively (32.7 ± 26 versus 23.0 ± 14.7 IU/L; p = 0.04) and on postoperative day 1 (29.7 ± 32 versus 10.3 ± 11.7 IU/L; p = 0.019). Magnesium sulfate prophylaxis prevents hypomagnesemia and reduces the incidence and severity of VTs postoperatively, possibly by enhancing myocardial protection.
This article has been cited by other articles:
|
|
 |
|
  R. C. Cook, K. H. Humphries, K. Gin, M. T. Janusz, R. S. Slavik, V. Bernstein, M. Tholin, and M. K. Lee Prophylactic Intravenous Magnesium Sulphate in Addition to Oral {beta}-Blockade Does Not Prevent Atrial Arrhythmias After Coronary Artery or Valvular Heart Surgery: A Randomized, Controlled Trial Circulation, September 15, 2009; 120(11_suppl_1): S163 - S169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Burgess, M. J. Kilborn, and A. C. Keech Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis Eur. Heart J., December 1, 2006; 27(23): 2846 - 2857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 39S - 47S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Miller, E Crystal, M Garfinkle, C Lau, I Lashevsky, and S J Connolly Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis Heart, May 1, 2005; 91(5): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rostron, A. Sanni, and J. Dunning Does magnesium prophylaxis reduce the incidence of atrial fibrillation following coronary bypass surgery? Interact CardioVasc Thorac Surg, February 1, 2005; 4(1): 52 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Hazelrigg, T. M. Boley, I. B. Cetindag, K. P. Moulton, G. L. Trammell, J. E. Polancic, T. S. Shawgo, J. A. Quin, and S. Verhulst The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting Ann. Thorac. Surg., March 1, 2004; 77(3): 824 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kaplan, M. S. Kut, U. A. Icer, and M. M. Demirtas Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 344 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Forlani, R. De Paulis, S. de Notaris, P. Nardi, F. Tomai, I. Proietti, A. S. Ghini, and L. Chiariello Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting Ann. Thorac. Surg., September 1, 2002; 74(3): 720 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Toraman, E. H. Karabulut, H. C. Alhan, S. Dagdelen, and S. Tarcan Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting Ann. Thorac. Surg., October 1, 2001; 72(4): 1256 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Solomon, A. K. Berger, K. K. Trivedi, R. L. Hannan, and N. M. Katz The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation Ann. Thorac. Surg., January 1, 2000; 69(1): 126 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Hogue Jr and M. L. Hyder Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment Ann. Thorac. Surg., January 1, 2000; 69(1): 300 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Ravn, S. D. Kristensen, V. E. Hjortdal, K. Thygesen, and S. E. r Husted Early Administration of Intravenous Magnesium Inhibits Arterial Thrombus Formation Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3620 - 3625. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
